Indegene Limited

Bajaj Allianz Life Insurance bought 952,381 shares of Indegene Limited for ₹50.00 Cr at ₹525.00 apiece in a block deal on August 6, 2026.

A provider of analytics, technology, and specialized services to life science and healthcare organizations worldwide. Indegene delivers integrated solutions spanning commercial, medical, regulatory, and safety domains, combining data-driven insights with advanced technology platforms. The company serves pharmaceutical, biotech, and healthcare firms seeking to optimize operations, enhance decision-making, and improve market performance through evidence-based approaches and digital transformation.

Now wholly owned by Bajaj Finserv after the Bajaj Group bought out Allianz SE's 26% stake in March 2025 for Rs 24,180 crore. Total AUM over Rs 1.2 lakh crore. Flagship Pure Stock Fund manages over Rs 7,200 crore as a Shariah-compliant Indian equity book. Active investor across large and midcap names through ULIP and group fund vehicles.